Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05944003 · ClinicalTrials.gov registry record

Resuscitative Thoracotomy Practices

A clinical trial, sponsored by Methodist Health System.

Completed
Registry status
500
Enrollment target

NCT05944003: Completed study, sponsored by Methodist Health System.

NCT05944003 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05944003 has completed, sponsored by Methodist Health System.

COMPLETED
Registry status
500 participants
Enrollment target

Study Summary

Resuscitative thoracotomies (RT) are an effective life saving measure in appropriate populations \[1-8\]. Unfortunately, when used outside of these populations the mortality rate is typically more than 90% \[1-8\]. Western Trauma Association and Eastern Association for the Surgery of Trauma have provided guidelines for which trauma patients are a candidate for RT \[1-3\].

Primary Outcome

Determine the rate of RT at MDMC. Particularly, if there was an increase during the COVID-19 pandemic, which would lead to greater exposure to transmissible disease

Interventions

  • PROCEDURE Resuscitative thoracotomies

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2022-05-18
Est. Completion 2025-09-18
Methodist Health System

125 total trials

What the finished NCT05944003 record still lists

NCT05944003 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Resuscitative thoracotomies is the first listed.

NCT05944003 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05944003 about?

NCT05944003 is a clinical study titled "Resuscitative Thoracotomy Practices". Resuscitative thoracotomies (RT) are an effective life saving measure in appropriate populations \[1-8\]. Unfortunately, when used outside of these populations the mortality rate is typically more than 90% \[1-8\]. Western Trauma Association and Eastern Association for the Surgery of Trauma have pro...

What is the current status of trial NCT05944003?

This trial is currently completed. The enrollment target is 500 participants. The study started on 2022-05-18. Estimated completion is 2025-09-18.

What interventions are being tested in trial NCT05944003?

The interventions under investigation include: Resuscitative thoracotomies (PROCEDURE).

Who is sponsoring clinical trial NCT05944003?

This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05944003, the US trial registry maintained by the National Library of Medicine. NCT05944003 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.